Haase, D., Stevenson, K., Neuberg, D., Maciejewski, J., Nazha, A., Sekeres, M., . . . Committee, I. W. G. F. M. M. P. (2019). TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Springer Nature.

Haase, D., et al. TP53 Mutation Status Divides Myelodysplastic Syndromes with Complex Karyotypes into Distinct Prognostic Subgroups. Springer Nature, 2019.

Haase, D., et al. TP53 Mutation Status Divides Myelodysplastic Syndromes with Complex Karyotypes into Distinct Prognostic Subgroups. Springer Nature, 2019.